Destiny Pharma plc’s £8 Million Fundraise

Osborne Clarke advised finnCap Ltd and Shore Capital Stockbrokers Limited.The transaction involved the conditional £7 million placing and subscription and up to £1m open offer for…

This content is for Standard 1 Year members only.
Login Join Now
Giulia Di Palma

Author: Giulia Di Palma

This content is for Standard 1 Year members only.
Login Join Now